The crucial role of titin in fetal development: recurrent miscarriages and bone, heart and muscle anomalies characterise the severe end of titinopathies spectrum.


Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
09 2023
Historique:
received: 31 10 2022
accepted: 18 01 2023
medline: 23 8 2023
pubmed: 29 3 2023
entrez: 28 3 2023
Statut: ppublish

Résumé

Titin truncating variants (TTNtvs) have been associated with several forms of myopathies and/or cardiomyopathies. In homozygosity or in compound heterozygosity, they cause a wide spectrum of recessive phenotypes with a congenital or childhood onset. Most recessive phenotypes showing a congenital or childhood onset have been described in subjects carrying biallelic TTNtv in specific exons. Often karyotype or chromosomal microarray analyses are the only tests performed when prenatal anomalies are identified. Thereby, many cases caused by We performed a retrospective study analysing an international cohort of 93 published and 10 unpublished cases carrying biallelic TTNtv. We identified recurrent clinical features showing a significant correlation with the genotype, including fetal akinesia (up to 62%), arthrogryposis (up to 85%), facial dysmorphisms (up to 73%), joint (up to 17%), bone (up to 22%) and heart anomalies (up to 27%) resembling complex, syndromic phenotypes. We suggest

Sections du résumé

BACKGROUND
Titin truncating variants (TTNtvs) have been associated with several forms of myopathies and/or cardiomyopathies. In homozygosity or in compound heterozygosity, they cause a wide spectrum of recessive phenotypes with a congenital or childhood onset. Most recessive phenotypes showing a congenital or childhood onset have been described in subjects carrying biallelic TTNtv in specific exons. Often karyotype or chromosomal microarray analyses are the only tests performed when prenatal anomalies are identified. Thereby, many cases caused by
METHODS
We performed a retrospective study analysing an international cohort of 93 published and 10 unpublished cases carrying biallelic TTNtv.
RESULTS
We identified recurrent clinical features showing a significant correlation with the genotype, including fetal akinesia (up to 62%), arthrogryposis (up to 85%), facial dysmorphisms (up to 73%), joint (up to 17%), bone (up to 22%) and heart anomalies (up to 27%) resembling complex, syndromic phenotypes.
CONCLUSION
We suggest

Identifiants

pubmed: 36977548
pii: jmg-2022-109018
doi: 10.1136/jmg-2022-109018
doi:

Substances chimiques

Connectin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

866-873

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Maria Francesca Di Feo (MF)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (DINOGMI), University of Genoa, Genova, Italy mfrancesca.difeo@gmail.com.

Victoria Lillback (V)

Folkhälsan Research Center, Helsinki, Uusimaa, Finland.
University of Helsinki Department of Medical and Clinical Genetics, Helsinki, Uusimaa, Finland.

Manu Jokela (M)

Tampere University Hospital, Tampere, Pirkanmaa, Finland.
TYKS Turku University Hospital, Turku, Varsinais-Suomi, Finland.

Meriel McEntagart (M)

Department of Medical Genetics, St George's University of London, London, London, UK.

Tessa Homfray (T)

St George's University of London, London, London, UK.

Elisa Giorgio (E)

Department of Molecular Medicine, University of Pavia, Pavia, Lombardia, Italy.
Fondazione Istituto Neurologico Nazionale C Mondino Istituto di Ricovero e Cura a Carattere Scientifico, Pavia, Lombardia, Italy.

Guido C Casalis Cavalchini (GC)

Medical Genetics Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Piemonte, Italy.

Alfredo Brusco (A)

Department of Medical Sciences, University of Turin School of Medicine, Torino, Piemonte, Italy.

Maria Iascone (M)

Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, BG, Italy.

Luigina Spaccini (L)

Unità di Genetica Medica, UOC Ostetricia e Ginecologia, Ospedale dei Bambini Vittore Buzzi, Milano, Lombardia, Italy.

Patrizia D'Oria (P)

UOC Ostetrica e Ginecologia, Ospedale Bolognini di Seriate, Seriate, Lombardia, Italy.

Marco Savarese (M)

Folkhälsan Research Center, Helsinki, Uusimaa, Finland.
Department of Medical Genetics, University of Helsinki, Helsinki, Uusimaa, Finland.

Bjarne Udd (B)

Folkhälsan Research Center, Helsinki, Uusimaa, Finland.
Tampere University Hospital Department of Musculoskeletal Diseases, Tampere, Pirkanmaa, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH